BiotechTubeBiotechTube
Home/Nuvectis Pharma/Enrique Poradosu
EP

Enrique Poradosu

Executive Vice President, Chief Scientific and Business Officer

Nuvectis Pharma

Therapeutic Areas

Oncology

Nuvectis Pharma Pipeline

DrugIndicationPhase
NXP900Advanced solid tumorsPhase 1b
NXP800Platinum-resistant, ARID1a-mutated ovarian cancerPhase 1b

Leadership Team at Nuvectis Pharma

RB
Ron Bentsur
Chairman, Chief Executive Officer and President
SS
Shay Shemesh
Executive Vice President, Chief Development and Operations Officer
View full Nuvectis Pharma profile